J Pediatr Infect Dis 2017; 12(03): 171-175
DOI: 10.1055/s-0037-1602828
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Antimicrobial Stewardship for Newborns in the Neonatal Intensive Care Unit

Rebecca Schein
1   Division of Pediatric Infectious Diseases, Department of Pediatrics and Human Development, Michigan State University, College of Human Medicine, East Lansing, Michigan, United States
,
B. Keith English
1   Division of Pediatric Infectious Diseases, Department of Pediatrics and Human Development, Michigan State University, College of Human Medicine, East Lansing, Michigan, United States
› Author Affiliations
Further Information

Publication History

08 December 2016

26 December 2016

Publication Date:
17 May 2017 (online)

Abstract

Overuse of antibiotics causing antibiotic resistance, an increase in Clostridium difficile infections, and increased adverse drug reactions is a growing problem. To combat this growing threat, the Centers for Disease Control started a program to improve the appropriate use of antimicrobials that focuses on antimicrobial stewardship. In the neonatal intensive care unit (NICU) medically fragile infants are commonly exposed to antibiotics resulting in a growing interest in applying antimicrobial stewardship principles in this patient population. The lack of treatment guidelines and the relatively narrow spectrum of individual antibiotics used to make the NICU a unique environment requiring a specialized approach to antimicrobial stewardship. This article examines the current antibiotic treatment data for common NICU illnesses including early and late-onset sepsis, pneumonia, and necrotizing enterocolitis, then reviews current recommendations for antimicrobial stewardship.

 
  • References

  • 1 Barlam TF, Cosgrove SE, Abbo LM. , et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016; 62 (10) e51-e77
  • 2 Magsarili HK, Girotto JE, Bennett NJ, Nicolau DP. Making a case for pediatric antimicrobial stewardship programs. Pharmacotherapy 2015; 35 (11) 1026-1036
  • 3 Metsvaht T, Nellis G, Varendi H. , et al. High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination. BMC Pediatr 2015; 15: 41
  • 4 Cantey JB, Wozniak PS, Sánchez PJ. Prospective surveillance of antibiotic use in the neonatal intensive care unit: results from the SCOUT study. Pediatr Infect Dis J 2015; 34 (03) 267-272
  • 5 Patel SJ, Saiman L, Duchon JM, Evans D, Ferng Y-H, Larson E. Development of an antimicrobial stewardship intervention using a model of actionable feedback. Interdiscip Perspect Infect Dis 2012; 2012: 150367
  • 6 Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev 2014; 27 (01) 21-47
  • 7 Hornik CP, Fort P, Clark RH. , et al. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev 2012; 88 (Suppl. 02) S69-S74
  • 8 Polin RA. ; Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012; 129 (05) 1006-1015
  • 9 Centers for Disease Control and Prevention. Prevention of Perinatal Group B Streptococcal Disease: Revised Guidelines from CDC, 2010. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5910a1.htm . Accessed June 20, 2016
  • 10 Mukhopadhyay S, Dukhovny D, Mao W, Eichenwald EC, Puopolo KM. 2010 perinatal GBS prevention guideline and resource utilization. Pediatrics 2014; 133 (02) 196-203
  • 11 Pasha YZ, Ahmadpour-Kacho M, Behmadi R, Jahangir T. 3-day versus 5-day course of intravenous antibiotics for suspected early onset neonatal sepsis: a randomized controlled trial. Iran J Pediatr 2014; 24 (06) 673-678
  • 12 Saini SS, Dutta S, Ray P, Narang A. Short course versus 7-day course of intravenous antibiotics for probable neonatal septicemia: a pilot, open-label, randomized controlled trial. Indian Pediatr 2011; 48 (01) 19-24
  • 13 Stoll BJ, Hansen N, Fanaroff AA. , et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110 (2 Pt 1): 285-291
  • 14 Stoll BJ, Hansen N. Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol 2003; 27 (04) 293-301
  • 15 Rubin LG, Sánchez PJ, Siegel J, Levine G, Saiman L, Jarvis WR. ; Pediatric Prevention Network. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices. Pediatrics 2002; 110 (04) e42
  • 16 Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000; 106 (06) 1387-1390
  • 17 Ericson JE, Popoola VO, Smith PB. , et al. Burden of invasive Staphylococcus aureus infections in hospitalized infants. JAMA Pediatr 2015; 169 (12) 1105-1111
  • 18 Nelson MU, Gallagher PG. Methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit. Semin Perinatol 2012; 36 (06) 424-430
  • 19 Ericson JE, Thaden J, Cross HR. , et al; Antibacterial Resistance Leadership Group. No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants. Pediatr Infect Dis J 2015; 34 (04) 371-375
  • 20 Thaden JT, Ericson JE, Cross H. , et al; Antibacterial Resistance Leadership Group. Survival benefit of empirical therapy for Staphylococcus aureus bloodstream infections in infants. Pediatr Infect Dis J 2015; 34 (11) 1175-1179
  • 21 Edwards MS. Antibacterial therapy in pregnancy and neonates. Clin Perinatol 1997; 24 (01) 251-266
  • 22 Garcia-Prats JA, Cooper TR, Schneider VF, Stager CE, Hansen TN. Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics 2000; 105 (3 Pt 1): 523-527
  • 23 Duke T. Neonatal pneumonia in developing countries. Arch Dis Child Fetal Neonatal Ed 2005; 90 (03) F211-F219
  • 24 Bennett NJ, Tabarani CM, Bartholoma NM. , et al. Unrecognized viral respiratory tract infections in premature infants during their birth hospitalization: a prospective surveillance study in two neonatal intensive care units. J Pediatr 2012; 161 (05) 814-818
  • 25 Ronchi A, Michelow IC, Chapin KC. , et al. Viral respiratory tract infections in the neonatal intensive care unit: the VIRIoN-I study. J Pediatr 2014; 165 (04) 690-696
  • 26 Verboon-Maciolek MA, Krediet TG, Gerards LJ, Fleer A, van Loon TM. Clinical and epidemiologic characteristics of viral infections in a neonatal intensive care unit during a 12-year period. Pediatr Infect Dis J 2005; 24 (10) 901-904
  • 27 Engle WD, Jackson GL, Sendelbach D. , et al. Neonatal pneumonia: comparison of 4 vs 7 days of antibiotic therapy in term and near-term infants. J Perinatol 2000; 20 (07) 421-426
  • 28 Torrazza RM, Neu J. The altered gut microbiome and necrotizing enterocolitis. Clin Perinatol 2013; 40 (01) 93-108
  • 29 Cotten CM, Taylor S, Stoll B. , et al; NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009; 123 (01) 58-66
  • 30 Alexander VN, Northrup V, Bizzarro MJ. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 2011; 159 (03) 392-397
  • 31 Shah D, Sinn JK. Antibiotic regimens for the empirical treatment of newborn infants with necrotising enterocolitis. In: The Cochrane Collaboration, ed. Cochrane Database of Systematic Reviews. Chichester, United Kingdom: John Wiley & Sons, Ltd; 2012
  • 32 Luo L-J, Li X, Yang K-D, Lu J-Y, Li L-Q. Broad-spectrum antibiotic plus metronidazole may not prevent the deterioration of necrotizing enterocolitis from stage ii to iii in full-term and near-term infants: a propensity score-matched cohort study. Medicine (Baltimore) 2015; 94 (42) e1862
  • 33 Autmizguine J, Hornik CP, Benjamin Jr DK. , et al; Best Pharmaceuticals for Children Act—Pediatric Trials Network Administrative Core Committee. Anaerobic antimicrobial therapy after necrotizing enterocolitis in VLBW infants. Pediatrics 2015; 135 (01) e117-e125
  • 34 Solomkin JS, Mazuski JE, Bradley JS. , et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50 (02) 133-164
  • 35 Patel SJ, Oshodi A, Prasad P. , et al. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance. Pediatr Infect Dis J 2009; 28 (12) 1047-1051
  • 36 Benitz WE. Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis. Clin Perinatol 2010; 37 (02) 421-438
  • 37 Patel SJ, Saiman L. Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit. Semin Perinatol 2012; 36 (06) 431-436
  • 38 Centers for Disease Control and Prevention. Get Smart for Healthcare. Available at: http://www.cdc.gov/getsmart/healthcare/ . Accessed June 21, 2016.
  • 39 Tolia VN, Desai S, Qin H. , et al. Implementation of an automatic stop order and initial antibiotic exposure in very low birth weight infants. Am J Perinatol 2017; 34 (02) 105-110
  • 40 Centers for Disease Control and Prevention. Core Elements of Hospital Antibiotic Stewardship Programs. Available at: http://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html . Accessed June 21, 2016